Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone
CA 2124792 C · Owner: Boyce, Rogely W. · Inventors: Geddes, Ann D.; Boyce, Rogely W.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides methods of increasing bone mass in a human or other animal subject afflicted with , osteoporosis comprising a thirty(30)-day treatment period comprised of a , parathyroid hormone administration regimen and a bisphosphonate administration regimen, wherein (a) said parathyroid hormone administration regimen comprises the administration to said subject of parathyroid hormone at a level of from about 4 IU/kg per day to about 15 IU/kg per day that said parathyroid hormone is administered, provided that said parathyroid hormone is administered at least one day every seven days of every said thirty(30)-day treatment period; and wherein (b) said bisphosphonate …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 15, 1992 and granted July 4, 2000. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 15, 2012.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 15, 2014.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.